NCT04437823View on ClinicalTrials.gov

Efficacy of Intravenous Infusions of Stem Cells in the Treatment of COVID-19 Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

October 31, 2021

Study Completion Date

November 30, 2021

Conditions
Corona Virus Infection
Interventions
BIOLOGICAL

Intravenous Infusions of Stem Cells

Cultured stem cells will be injected at days 1, 3 and 5 intravenously. While patients will be monitored and evaluated for various hematological and organ functions at baseline (day 0) and days 1, 3, 5, 7, 14, 21 and 30

Trial Locations (1)

54550

Jinnah Hospital, Lahore

All Listed Sponsors
collaborator

Johns Hopkins University

OTHER

lead

Jinnah Hospital

OTHER

NCT04437823 - Efficacy of Intravenous Infusions of Stem Cells in the Treatment of COVID-19 Patients | Biotech Hunter | Biotech Hunter